Monica Casucci, group leader of the innovative immunotherapies unit at IRCCS Ospedale San Raffaele, was awarded by the European Research Council, to refine her outstanding research work on a novel CAR specific for the CD44v6 antigen and strategies to improve CAR-T cell activity against solid tumors. 
Congratulations from the whole CARAMBA team to Monica!


Share This